ArticleArchives of toxicology2026
Chemicals in plastics differentially affect the transcriptome of MCF-7 breast cancer cells.
Article in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Humans are exposed to chemicals that leach from plastics, yet many remain data-poor and lack toxicological evaluation. High-throughput transcriptomics (HTTr) provides a scalable way to screen chemicals and generate mechanistic insights relevant to human health risk assessment. We applied HTTr in MCF-7 breast cancer cells to assess chemicals across several concentrations (0.001-50 µM) used in plastics and dyes. Transcriptomic points of departure (tPODs) were derived from general gene perturbations, including pathway-level and estrogen receptor α (ERα)-specific changes. We also used transcriptomic biomarkers to evaluate ERα activity and cellular stress responses. Most plastic chemicals showed similar toxicological potency, with tPODs falling within one order of magnitude. Bisphenol K was the most potent, activating ERα at the lowest concentrations, followed by plastic additive 08 and bisphenol A (BPA). Despite similar overall potency, transcriptomic biomarkers revealed distinct mechanisms. Chemicals structurally similar to BPA activated ERα, whereas others with different functional groups inhibited the ERα biomarker. Pathway and upstream regulator analyses further indicated that BPA-like chemicals consistently perturbed ERα-related pathways, while other chemicals enriched fewer gene sets and often produced opposite directional responses. At the highest concentrations tested, several chemicals also activated stress-response biomarkers and suppressed proliferation. Overall, these results suggest that while many plastic chemicals exhibit comparable in vitro potency, they diverge in ERα regulation and downstream biological pathways. This study demonstrates the reproducibility and value of HTTr for chemical screening, supports grouping ERα-active plastic chemicals for read-across, and underscores the need for additional evaluation of plastic chemicals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.